Avaleht › Geograafiline atroofia › Florida
Geograafiline atroofia kliinilised uuringud osariigis Florida
8 uuringut haiguse Geograafiline atroofia jaoks otsivad osalejaid osariigis Florida.
Linnad osariigis Florida
Ametlik uuringutekst (inglise keeles)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Group of Florida, Fort Lauderdale
- VitreoRetinal Associates, PA, Gainesville
- Retina Specialty Institute, Pensacola
- ja veel 1
VärbamineFaas 2/3
Vanused 60 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT06635148A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Vitreo Retinal Associates - Gainesville- Site Number : 8400004, Gainesville
- Retina Vitreous Associates of Florida - St. Petersburg- Site Number : 8400002, St. Petersburg
VärbamineFaas 1/2
Vanused 60 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07215234A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Advanced Retina Institute-Ophthalmology, Bonita Springs
- Advanced Research, Coral Springs
- Retina Group of Florida, Fort Lauderdale
- ja veel 11
VärbamineFaas 3
Vanused 50–85 · Kõik sood · Uuendatud 18. sept 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- Retina Vitreous Associates of Florida, St. Petersburg
VärbamineFaas 2
Vanused 50 ja vanemad · Kõik sood · Uuendatud 15. sept 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Florida Retina Institute, Orlando
- Retina Specialty Institute, Pensacola
- Retina Group of Florida, Sarasota
- ja veel 1
VärbamineFaas 2
Vanused 55 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Retina Specialty Institute, Pensacola
VärbamineFaas 1
Vanused 50 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT03178149Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. juuni 2026 · NCT03011541Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Sarasota Retina Institute, Sarasota
Värbamine
Vanused 65 ja vanemad · Kõik sood · Uuendatud 3. dets 2024 · NCT05438732Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.